Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignanciesMENICHETTI, F; MARTINO, P; FASOLA, G et al.Antimicrobial agents and chemotherapy. 1994, Vol 38, Num 9, pp 2041-2046, issn 0066-4804Article

Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotypeAVERSA, F; TABILIO, A; REISNER, Y et al.The New England journal of medicine. 1998, Vol 339, Num 17, pp 1186-1193, issn 0028-4793Article

In vivo targeting of Hodgkin and Reed-Sternberg cells of Hodgkin's disease with monoclonal antibody Ber-H2 (CD30) : immunohistological evidenceFALINI, B; FLENGHI, L; AVERSA, F et al.British journal of haematology. 1992, Vol 82, Num 1, pp 38-45, issn 0007-1048Conference Paper

Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies : A randomized, placebo-controlled, double-blind, multicenter trialMENICHETTI, F; DEL FAVERO, A; CAIOZZO, A et al.Clinical infectious diseases. 1999, Vol 28, Num 2, pp 250-255, issn 1058-4838Conference Paper

Domiciliary treatment of febrile episodes in cancer patients : a prospective randomized trial comparing oral versus parenteral empirical antibiotic treatmentMINOTTI, V; GENTILE, G; DEL FAVERO, A et al.Supportive care in cancer. 1999, Vol 7, Num 3, pp 134-139, issn 0941-4355Conference Paper

Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxinFALINI, B; BOLOGNESI, A; BARBABIETOLA, G et al.Lancet (British edition). 1992, Vol 339, Num 8803, pp 1195-1196, issn 0140-6736Article